nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—thyroid cancer	0.522	1	CbGaD
Telmisartan—ABCG2—Vandetanib—thyroid cancer	0.0914	0.273	CbGbCtD
Telmisartan—ABCC2—Sorafenib—thyroid cancer	0.0609	0.182	CbGbCtD
Telmisartan—ABCG2—Sorafenib—thyroid cancer	0.0551	0.165	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—thyroid cancer	0.037	0.111	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—thyroid cancer	0.0334	0.1	CbGbCtD
Telmisartan—CYP2C19—Sorafenib—thyroid cancer	0.0246	0.0736	CbGbCtD
Telmisartan—ABCB1—Sorafenib—thyroid cancer	0.0199	0.0594	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—thyroid cancer	0.0121	0.036	CbGbCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00126	0.0553	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors—THRB—thyroid cancer	0.000928	0.0408	CbGpPWpGaD
Telmisartan—SLCO1B3—Recycling of bile acids and salts—RXRA—thyroid cancer	0.000923	0.0406	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—TSHR—thyroid cancer	0.000899	0.0396	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.000733	0.0323	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 trafficking events—TSHR—thyroid cancer	0.00071	0.0312	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.00061	0.0269	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.000534	0.0235	CbGpPWpGaD
Telmisartan—AGTR1—Peptide GPCRs—TSHR—thyroid cancer	0.000494	0.0217	CbGpPWpGaD
Telmisartan—SLCO1B3—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000482	0.0212	CbGpPWpGaD
Telmisartan—ABCG2—Iron uptake and transport—CP—thyroid cancer	0.000414	0.0182	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors—RXRA—thyroid cancer	0.000394	0.0173	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—EPO—thyroid cancer	0.000392	0.0172	CbGpPWpGaD
Telmisartan—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000379	0.0167	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.000358	0.0158	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000354	0.0156	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000311	0.0137	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000294	0.0129	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000293	0.0129	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000257	0.0113	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CALCB—thyroid cancer	0.000256	0.0113	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000231	0.0101	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000228	0.01	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—RXRA—thyroid cancer	0.000224	0.00986	CbGpPWpGaD
Telmisartan—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000216	0.00179	CcSEcCtD
Telmisartan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000213	0.00177	CcSEcCtD
Telmisartan—Renal failure acute—Epirubicin—thyroid cancer	0.000212	0.00176	CcSEcCtD
Telmisartan—Increased appetite—Epirubicin—thyroid cancer	0.000208	0.00173	CcSEcCtD
Telmisartan—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000208	0.00173	CcSEcCtD
Telmisartan—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000207	0.00172	CcSEcCtD
Telmisartan—Urticaria—Sorafenib—thyroid cancer	0.000207	0.00171	CcSEcCtD
Telmisartan—Body temperature increased—Sorafenib—thyroid cancer	0.000206	0.00171	CcSEcCtD
Telmisartan—Abdominal pain—Sorafenib—thyroid cancer	0.000206	0.00171	CcSEcCtD
Telmisartan—Renal impairment—Epirubicin—thyroid cancer	0.000206	0.00171	CcSEcCtD
Telmisartan—Purpura—Epirubicin—thyroid cancer	0.000203	0.00168	CcSEcCtD
Telmisartan—Vascular purpura—Doxorubicin—thyroid cancer	0.000202	0.00168	CcSEcCtD
Telmisartan—Eczema—Doxorubicin—thyroid cancer	0.000201	0.00167	CcSEcCtD
Telmisartan—Hypoglycaemia—Epirubicin—thyroid cancer	0.000201	0.00166	CcSEcCtD
Telmisartan—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.0002	0.00166	CcSEcCtD
Telmisartan—Renal failure acute—Doxorubicin—thyroid cancer	0.000196	0.00163	CcSEcCtD
Telmisartan—Osteoarthritis—Epirubicin—thyroid cancer	0.000196	0.00162	CcSEcCtD
Telmisartan—Pain in extremity—Epirubicin—thyroid cancer	0.000196	0.00162	CcSEcCtD
Telmisartan—Increased appetite—Doxorubicin—thyroid cancer	0.000193	0.0016	CcSEcCtD
Telmisartan—Migraine—Epirubicin—thyroid cancer	0.000193	0.0016	CcSEcCtD
Telmisartan—Hypersensitivity—Sorafenib—thyroid cancer	0.000192	0.00159	CcSEcCtD
Telmisartan—Renal impairment—Doxorubicin—thyroid cancer	0.00019	0.00158	CcSEcCtD
Telmisartan—Face oedema—Epirubicin—thyroid cancer	0.000189	0.00157	CcSEcCtD
Telmisartan—Purpura—Doxorubicin—thyroid cancer	0.000188	0.00156	CcSEcCtD
Telmisartan—Asthenia—Sorafenib—thyroid cancer	0.000187	0.00155	CcSEcCtD
Telmisartan—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000186	0.00154	CcSEcCtD
Telmisartan—Pruritus—Sorafenib—thyroid cancer	0.000184	0.00153	CcSEcCtD
Telmisartan—Blood creatinine increased—Epirubicin—thyroid cancer	0.000183	0.00152	CcSEcCtD
Telmisartan—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000183	0.00804	CbGpPWpGaD
Telmisartan—Pain in extremity—Doxorubicin—thyroid cancer	0.000181	0.0015	CcSEcCtD
Telmisartan—Osteoarthritis—Doxorubicin—thyroid cancer	0.000181	0.0015	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—SST—thyroid cancer	0.000181	0.00795	CbGpPWpGaD
Telmisartan—Dry skin—Epirubicin—thyroid cancer	0.000179	0.00149	CcSEcCtD
Telmisartan—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000179	0.00148	CcSEcCtD
Telmisartan—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000178	0.00784	CbGpPWpGaD
Telmisartan—Migraine—Doxorubicin—thyroid cancer	0.000178	0.00148	CcSEcCtD
Telmisartan—Hypokalaemia—Epirubicin—thyroid cancer	0.000178	0.00148	CcSEcCtD
Telmisartan—Diarrhoea—Sorafenib—thyroid cancer	0.000178	0.00148	CcSEcCtD
Telmisartan—Breast disorder—Epirubicin—thyroid cancer	0.000177	0.00147	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000175	0.00771	CbGpPWpGaD
Telmisartan—Face oedema—Doxorubicin—thyroid cancer	0.000175	0.00145	CcSEcCtD
Telmisartan—Gastritis—Epirubicin—thyroid cancer	0.000173	0.00144	CcSEcCtD
Telmisartan—Muscular weakness—Epirubicin—thyroid cancer	0.000173	0.00143	CcSEcCtD
Telmisartan—Dizziness—Sorafenib—thyroid cancer	0.000172	0.00143	CcSEcCtD
Telmisartan—Abdominal distension—Epirubicin—thyroid cancer	0.00017	0.00141	CcSEcCtD
Telmisartan—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00017	0.00141	CcSEcCtD
Telmisartan—Asthma—Epirubicin—thyroid cancer	0.000169	0.0014	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—RXRA—thyroid cancer	0.000168	0.00741	CbGpPWpGaD
Telmisartan—Eosinophilia—Epirubicin—thyroid cancer	0.000167	0.00139	CcSEcCtD
Telmisartan—Dry skin—Doxorubicin—thyroid cancer	0.000166	0.00138	CcSEcCtD
Telmisartan—Vomiting—Sorafenib—thyroid cancer	0.000165	0.00137	CcSEcCtD
Telmisartan—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000165	0.00137	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000165	0.00725	CbGpPWpGaD
Telmisartan—Hypokalaemia—Doxorubicin—thyroid cancer	0.000165	0.00137	CcSEcCtD
Telmisartan—Angina pectoris—Epirubicin—thyroid cancer	0.000165	0.00137	CcSEcCtD
Telmisartan—Rash—Sorafenib—thyroid cancer	0.000164	0.00136	CcSEcCtD
Telmisartan—Dermatitis—Sorafenib—thyroid cancer	0.000164	0.00136	CcSEcCtD
Telmisartan—Breast disorder—Doxorubicin—thyroid cancer	0.000164	0.00136	CcSEcCtD
Telmisartan—Headache—Sorafenib—thyroid cancer	0.000163	0.00135	CcSEcCtD
Telmisartan—Bronchitis—Epirubicin—thyroid cancer	0.000163	0.00135	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000161	0.00709	CbGpPWpGaD
Telmisartan—Gastritis—Doxorubicin—thyroid cancer	0.00016	0.00133	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—thyroid cancer	0.00016	0.00132	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000159	0.00699	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000158	0.00696	CbGpPWpGaD
Telmisartan—Dysuria—Epirubicin—thyroid cancer	0.000158	0.00131	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000158	0.00694	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000158	0.00694	CbGpPWpGaD
Telmisartan—Abdominal distension—Doxorubicin—thyroid cancer	0.000158	0.00131	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000157	0.0013	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—thyroid cancer	0.000157	0.00692	CbGpPWpGaD
Telmisartan—Asthma—Doxorubicin—thyroid cancer	0.000156	0.0013	CcSEcCtD
Telmisartan—Pollakiuria—Epirubicin—thyroid cancer	0.000156	0.0013	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000156	0.00685	CbGpPWpGaD
Telmisartan—Eosinophilia—Doxorubicin—thyroid cancer	0.000155	0.00129	CcSEcCtD
Telmisartan—Nausea—Sorafenib—thyroid cancer	0.000155	0.00128	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—thyroid cancer	0.000152	0.00126	CcSEcCtD
Telmisartan—Pneumonia—Epirubicin—thyroid cancer	0.000152	0.00126	CcSEcCtD
Telmisartan—Infestation NOS—Epirubicin—thyroid cancer	0.000151	0.00125	CcSEcCtD
Telmisartan—Infestation—Epirubicin—thyroid cancer	0.000151	0.00125	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—thyroid cancer	0.000151	0.00125	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—thyroid cancer	0.000148	0.00123	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000148	0.00123	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—RXRA—thyroid cancer	0.000147	0.00648	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000147	0.00646	CbGpPWpGaD
Telmisartan—Urinary tract infection—Epirubicin—thyroid cancer	0.000147	0.00122	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—thyroid cancer	0.000147	0.00122	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—thyroid cancer	0.000146	0.00121	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000145	0.00121	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—CALCB—thyroid cancer	0.000145	0.00637	CbGpPWpGaD
Telmisartan—Pollakiuria—Doxorubicin—thyroid cancer	0.000145	0.0012	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—thyroid cancer	0.000144	0.00119	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000143	0.00631	CbGpPWpGaD
Telmisartan—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000143	0.00118	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.000143	0.00627	CbGpPWpGaD
Telmisartan—Epistaxis—Epirubicin—thyroid cancer	0.000142	0.00118	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—thyroid cancer	0.000141	0.00117	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—thyroid cancer	0.00014	0.00116	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—thyroid cancer	0.00014	0.00116	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—thyroid cancer	0.00014	0.00116	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—thyroid cancer	0.000138	0.00114	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CCND1—thyroid cancer	0.000138	0.00606	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000137	0.00604	CbGpPWpGaD
Telmisartan—Renal failure—Doxorubicin—thyroid cancer	0.000137	0.00114	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000137	0.00113	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—thyroid cancer	0.000136	0.00113	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—thyroid cancer	0.000136	0.00112	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—thyroid cancer	0.000136	0.00112	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—thyroid cancer	0.000135	0.00112	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—thyroid cancer	0.000134	0.00111	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—SLC5A5—thyroid cancer	0.000134	0.0059	CbGpPWpGaD
Telmisartan—Urinary tract disorder—Epirubicin—thyroid cancer	0.000134	0.00111	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—thyroid cancer	0.000133	0.00111	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—thyroid cancer	0.000133	0.0011	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—thyroid cancer	0.000133	0.0011	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—thyroid cancer	0.000133	0.0011	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000132	0.00109	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—thyroid cancer	0.000132	0.00109	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CALCB—thyroid cancer	0.000132	0.00579	CbGpPWpGaD
Telmisartan—Sinusitis—Doxorubicin—thyroid cancer	0.000131	0.00109	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—thyroid cancer	0.00013	0.00108	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—thyroid cancer	0.000128	0.00106	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000127	0.00557	CbGpPWpGaD
Telmisartan—Eye disorder—Epirubicin—thyroid cancer	0.000127	0.00105	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—thyroid cancer	0.000126	0.00105	CcSEcCtD
Telmisartan—Flushing—Epirubicin—thyroid cancer	0.000126	0.00104	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—thyroid cancer	0.000126	0.00104	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—thyroid cancer	0.000126	0.00104	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000125	0.00551	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000125	0.00548	CbGpPWpGaD
Telmisartan—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000125	0.00103	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—thyroid cancer	0.000124	0.00103	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000124	0.00103	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—thyroid cancer	0.000123	0.00102	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000123	0.00102	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—thyroid cancer	0.000123	0.00102	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—thyroid cancer	0.000123	0.00102	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—thyroid cancer	0.000122	0.00101	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—thyroid cancer	0.000122	0.00101	CcSEcCtD
Telmisartan—Chills—Epirubicin—thyroid cancer	0.000121	0.00101	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000121	0.00533	CbGpPWpGaD
Telmisartan—Arrhythmia—Epirubicin—thyroid cancer	0.000121	0.001	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—thyroid cancer	0.000121	0.001	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—TSHR—thyroid cancer	0.000119	0.00522	CbGpPWpGaD
Telmisartan—Mental disorder—Epirubicin—thyroid cancer	0.000119	0.000984	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000118	0.00519	CbGpPWpGaD
Telmisartan—Malnutrition—Epirubicin—thyroid cancer	0.000118	0.000977	CcSEcCtD
Telmisartan—Erythema—Epirubicin—thyroid cancer	0.000118	0.000977	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—thyroid cancer	0.000117	0.000971	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—thyroid cancer	0.000117	0.000969	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—thyroid cancer	0.000116	0.000964	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—thyroid cancer	0.000116	0.000964	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—thyroid cancer	0.000116	0.000963	CcSEcCtD
Telmisartan—Tension—Epirubicin—thyroid cancer	0.000116	0.000959	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—thyroid cancer	0.000115	0.000957	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—thyroid cancer	0.000114	0.000949	CcSEcCtD
Telmisartan—Back pain—Epirubicin—thyroid cancer	0.000114	0.000945	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.000114	0.005	CbGpPWpGaD
Telmisartan—Angiopathy—Doxorubicin—thyroid cancer	0.000114	0.000943	CcSEcCtD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000114	0.005	CbGpPWpGaD
Telmisartan—Muscle spasms—Epirubicin—thyroid cancer	0.000113	0.00094	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—thyroid cancer	0.000113	0.000938	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000113	0.000936	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—RXRA—thyroid cancer	0.000113	0.00495	CbGpPWpGaD
Telmisartan—Chills—Doxorubicin—thyroid cancer	0.000112	0.000932	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—thyroid cancer	0.000112	0.000928	CcSEcCtD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00011	0.00486	CbGpPWpGaD
Telmisartan—Mental disorder—Doxorubicin—thyroid cancer	0.00011	0.00091	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—HIF1A—thyroid cancer	0.000109	0.00481	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000109	0.000907	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—thyroid cancer	0.000109	0.000904	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—thyroid cancer	0.000109	0.000904	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—thyroid cancer	0.000109	0.000903	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—thyroid cancer	0.000107	0.000891	CcSEcCtD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000107	0.00472	CbGpPWpGaD
Telmisartan—Tension—Doxorubicin—thyroid cancer	0.000107	0.000888	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—thyroid cancer	0.000107	0.000886	CcSEcCtD
Telmisartan—Malaise—Epirubicin—thyroid cancer	0.000106	0.000881	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—thyroid cancer	0.000106	0.00467	CbGpPWpGaD
Telmisartan—Nervousness—Doxorubicin—thyroid cancer	0.000106	0.000878	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—thyroid cancer	0.000106	0.000878	CcSEcCtD
Telmisartan—Syncope—Epirubicin—thyroid cancer	0.000106	0.000877	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—thyroid cancer	0.000105	0.000875	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—thyroid cancer	0.000105	0.00087	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—thyroid cancer	0.000104	0.000864	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—thyroid cancer	0.000104	0.000859	CcSEcCtD
Telmisartan—Cough—Epirubicin—thyroid cancer	0.000103	0.000853	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—thyroid cancer	0.000102	0.000844	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—MINPP1—thyroid cancer	0.000101	0.00446	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000101	0.000839	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—PTCH1—thyroid cancer	0.000101	0.00444	CbGpPWpGaD
Telmisartan—Anaemia—Doxorubicin—thyroid cancer	0.000101	0.000836	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—thyroid cancer	0.0001	0.000832	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—thyroid cancer	0.0001	0.000832	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—thyroid cancer	0.0001	0.000832	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—thyroid cancer	0.0001	0.000829	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	9.96e-05	0.000826	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—thyroid cancer	9.91e-05	0.000822	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—thyroid cancer	9.83e-05	0.000816	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—thyroid cancer	9.81e-05	0.000814	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—thyroid cancer	9.8e-05	0.000813	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—thyroid cancer	9.78e-05	0.000811	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—NRG1—thyroid cancer	9.74e-05	0.00428	CbGpPWpGaD
Telmisartan—Palpitations—Doxorubicin—thyroid cancer	9.64e-05	0.000799	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—thyroid cancer	9.62e-05	0.000798	CcSEcCtD
Telmisartan—Oedema—Epirubicin—thyroid cancer	9.62e-05	0.000798	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—thyroid cancer	9.58e-05	0.000795	CcSEcCtD
Telmisartan—Infection—Epirubicin—thyroid cancer	9.55e-05	0.000793	CcSEcCtD
Telmisartan—Cough—Doxorubicin—thyroid cancer	9.52e-05	0.000789	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	9.51e-05	0.00418	CbGpPWpGaD
Telmisartan—Shock—Epirubicin—thyroid cancer	9.46e-05	0.000785	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—thyroid cancer	9.43e-05	0.000782	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—thyroid cancer	9.42e-05	0.000781	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—thyroid cancer	9.41e-05	0.000781	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—thyroid cancer	9.39e-05	0.000779	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—thyroid cancer	9.34e-05	0.000775	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—thyroid cancer	9.3e-05	0.000771	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—thyroid cancer	9.28e-05	0.00077	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—thyroid cancer	9.28e-05	0.00077	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—thyroid cancer	9.28e-05	0.00077	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—thyroid cancer	9.25e-05	0.000767	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—SST—thyroid cancer	9.23e-05	0.00406	CbGpPWpGaD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	9.22e-05	0.000765	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—thyroid cancer	9.17e-05	0.000761	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—thyroid cancer	9.17e-05	0.00076	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—thyroid cancer	9.08e-05	0.000753	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—thyroid cancer	8.99e-05	0.000745	CcSEcCtD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.95e-05	0.00394	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Doxorubicin—thyroid cancer	8.9e-05	0.000738	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—thyroid cancer	8.9e-05	0.000738	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CALCA—thyroid cancer	8.88e-05	0.00391	CbGpPWpGaD
Telmisartan—Infection—Doxorubicin—thyroid cancer	8.84e-05	0.000733	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	8.76e-05	0.000727	CcSEcCtD
Telmisartan—Shock—Doxorubicin—thyroid cancer	8.76e-05	0.000726	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—thyroid cancer	8.73e-05	0.000724	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—thyroid cancer	8.71e-05	0.000723	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—thyroid cancer	8.7e-05	0.000722	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—thyroid cancer	8.69e-05	0.00072	CcSEcCtD
Telmisartan—PPARG—Metabolism—MINPP1—thyroid cancer	8.65e-05	0.00381	CbGpPWpGaD
Telmisartan—Skin disorder—Doxorubicin—thyroid cancer	8.64e-05	0.000717	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—thyroid cancer	8.64e-05	0.000716	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—NDUFA13—thyroid cancer	8.62e-05	0.00379	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Doxorubicin—thyroid cancer	8.6e-05	0.000714	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—thyroid cancer	8.57e-05	0.000711	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—thyroid cancer	8.55e-05	0.000709	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—thyroid cancer	8.48e-05	0.000704	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—thyroid cancer	8.47e-05	0.000702	CcSEcCtD
Telmisartan—PPARG—Gene Expression—TRIM33—thyroid cancer	8.43e-05	0.00371	CbGpPWpGaD
Telmisartan—Decreased appetite—Epirubicin—thyroid cancer	8.36e-05	0.000693	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—thyroid cancer	8.32e-05	0.00069	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—thyroid cancer	8.3e-05	0.000689	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—thyroid cancer	8.29e-05	0.000688	CcSEcCtD
Telmisartan—Constipation—Epirubicin—thyroid cancer	8.22e-05	0.000682	CcSEcCtD
Telmisartan—Pain—Epirubicin—thyroid cancer	8.22e-05	0.000682	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	8.11e-05	0.000672	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—CHST14—thyroid cancer	8.11e-05	0.00357	CbGpPWpGaD
Telmisartan—Insomnia—Doxorubicin—thyroid cancer	8.05e-05	0.000668	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—MEN1—thyroid cancer	8.04e-05	0.00354	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—CP—thyroid cancer	8.01e-05	0.00353	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—TPR—thyroid cancer	8.01e-05	0.00353	CbGpPWpGaD
Telmisartan—Paraesthesia—Doxorubicin—thyroid cancer	7.99e-05	0.000663	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—thyroid cancer	7.93e-05	0.000658	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—thyroid cancer	7.93e-05	0.000657	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—thyroid cancer	7.91e-05	0.000656	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.88e-05	0.00347	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Epirubicin—thyroid cancer	7.86e-05	0.000652	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—thyroid cancer	7.83e-05	0.00065	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—CALCB—thyroid cancer	7.77e-05	0.00342	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	7.76e-05	0.00341	CbGpPWpGaD
Telmisartan—Decreased appetite—Doxorubicin—thyroid cancer	7.74e-05	0.000642	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—thyroid cancer	7.68e-05	0.000637	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—thyroid cancer	7.67e-05	0.000636	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—AKT1—thyroid cancer	7.66e-05	0.00337	CbGpPWpGaD
Telmisartan—Urticaria—Epirubicin—thyroid cancer	7.64e-05	0.000634	CcSEcCtD
Telmisartan—Pain—Doxorubicin—thyroid cancer	7.61e-05	0.000631	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—thyroid cancer	7.61e-05	0.000631	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—thyroid cancer	7.6e-05	0.000631	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—thyroid cancer	7.6e-05	0.000631	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	7.42e-05	0.00326	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TRIM33—thyroid cancer	7.36e-05	0.00324	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NDUFA13—thyroid cancer	7.36e-05	0.00324	CbGpPWpGaD
Telmisartan—Feeling abnormal—Doxorubicin—thyroid cancer	7.33e-05	0.000608	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—thyroid cancer	7.28e-05	0.000604	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—thyroid cancer	7.09e-05	0.000588	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—thyroid cancer	7.07e-05	0.000586	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—thyroid cancer	7.03e-05	0.000584	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—thyroid cancer	7.03e-05	0.000584	CcSEcCtD
Telmisartan—PPARG—Metabolism—CHST14—thyroid cancer	6.92e-05	0.00304	CbGpPWpGaD
Telmisartan—Asthenia—Epirubicin—thyroid cancer	6.9e-05	0.000572	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—thyroid cancer	6.8e-05	0.000564	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—TSHR—thyroid cancer	6.7e-05	0.00295	CbGpPWpGaD
Telmisartan—Diarrhoea—Epirubicin—thyroid cancer	6.58e-05	0.000546	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—thyroid cancer	6.56e-05	0.000544	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—HPGD—thyroid cancer	6.53e-05	0.00288	CbGpPWpGaD
Telmisartan—Asthenia—Doxorubicin—thyroid cancer	6.38e-05	0.00053	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—thyroid cancer	6.36e-05	0.000528	CcSEcCtD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.35e-05	0.00279	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MINPP1—thyroid cancer	6.31e-05	0.00278	CbGpPWpGaD
Telmisartan—Pruritus—Doxorubicin—thyroid cancer	6.3e-05	0.000522	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—thyroid cancer	6.12e-05	0.000507	CcSEcCtD
Telmisartan—PPARG—SREBP signalling—AKT1—thyroid cancer	6.1e-05	0.00269	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—THRB—thyroid cancer	6.1e-05	0.00268	CbGpPWpGaD
Telmisartan—Diarrhoea—Doxorubicin—thyroid cancer	6.09e-05	0.000505	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—TSHR—thyroid cancer	6.09e-05	0.00268	CbGpPWpGaD
Telmisartan—Rash—Epirubicin—thyroid cancer	6.06e-05	0.000503	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—thyroid cancer	6.06e-05	0.000503	CcSEcCtD
Telmisartan—Headache—Epirubicin—thyroid cancer	6.03e-05	0.0005	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6e-05	0.00264	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PRKAR1A—thyroid cancer	5.99e-05	0.00264	CbGpPWpGaD
Telmisartan—Dizziness—Doxorubicin—thyroid cancer	5.88e-05	0.000488	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	5.73e-05	0.00252	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	5.73e-05	0.00252	CbGpPWpGaD
Telmisartan—Nausea—Epirubicin—thyroid cancer	5.71e-05	0.000474	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—thyroid cancer	5.66e-05	0.000469	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.64e-05	0.00248	CbGpPWpGaD
Telmisartan—Rash—Doxorubicin—thyroid cancer	5.61e-05	0.000465	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—thyroid cancer	5.61e-05	0.000465	CcSEcCtD
Telmisartan—PPARG—Metabolism—HPGD—thyroid cancer	5.58e-05	0.00245	CbGpPWpGaD
Telmisartan—Headache—Doxorubicin—thyroid cancer	5.57e-05	0.000462	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—CDK1—thyroid cancer	5.46e-05	0.0024	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—RXRA—thyroid cancer	5.38e-05	0.00237	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NDUFA13—thyroid cancer	5.36e-05	0.00236	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.3e-05	0.00233	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—thyroid cancer	5.29e-05	0.000438	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—SST—thyroid cancer	5.21e-05	0.00229	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTCH1—thyroid cancer	5.18e-05	0.00228	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	5.11e-05	0.00225	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RXRA—thyroid cancer	5.06e-05	0.00223	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.06e-05	0.00222	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CHST14—thyroid cancer	5.04e-05	0.00222	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.04e-05	0.00222	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CALCA—thyroid cancer	5.02e-05	0.00221	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	4.98e-05	0.00219	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	4.98e-05	0.00219	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TCF7L1—thyroid cancer	4.91e-05	0.00216	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.9e-05	0.00216	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—RXRA—thyroid cancer	4.76e-05	0.00209	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—SST—thyroid cancer	4.73e-05	0.00208	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.61e-05	0.00203	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CALCA—thyroid cancer	4.56e-05	0.00201	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.52e-05	0.00199	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—PTEN—thyroid cancer	4.5e-05	0.00198	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	4.4e-05	0.00194	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.29e-05	0.00189	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	4.27e-05	0.00188	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CDK1—thyroid cancer	4.13e-05	0.00182	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—TPR—thyroid cancer	4.12e-05	0.00181	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HPGD—thyroid cancer	4.07e-05	0.00179	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MEN1—thyroid cancer	3.87e-05	0.0017	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TPR—thyroid cancer	3.75e-05	0.00165	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.74e-05	0.00165	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.73e-05	0.00164	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	3.69e-05	0.00162	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.61e-05	0.00159	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSHR—thyroid cancer	3.6e-05	0.00158	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRKAR1A—thyroid cancer	3.54e-05	0.00156	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.49e-05	0.00154	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MINPP1—thyroid cancer	3.41e-05	0.0015	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MEN1—thyroid cancer	3.38e-05	0.00149	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.35e-05	0.00147	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TPR—thyroid cancer	3.2e-05	0.00141	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PRKAR1A—thyroid cancer	3.15e-05	0.00139	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.14e-05	0.00138	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—thyroid cancer	3.07e-05	0.00135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTCH1—thyroid cancer	3.06e-05	0.00135	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.97e-05	0.00131	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.9e-05	0.00128	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	2.81e-05	0.00124	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SST—thyroid cancer	2.8e-05	0.00123	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CHST14—thyroid cancer	2.79e-05	0.00123	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CHST14—thyroid cancer	2.73e-05	0.0012	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.7e-05	0.00119	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.7e-05	0.00119	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CALCA—thyroid cancer	2.69e-05	0.00118	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.65e-05	0.00117	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.63e-05	0.00116	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—RXRA—thyroid cancer	2.59e-05	0.00114	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.49e-05	0.0011	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDK1—thyroid cancer	2.44e-05	0.00107	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC5A5—thyroid cancer	2.4e-05	0.00105	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—RXRA—thyroid cancer	2.36e-05	0.00104	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TPR—thyroid cancer	2.33e-05	0.00103	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PRKAR1A—thyroid cancer	2.3e-05	0.00101	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.3e-05	0.00101	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HPGD—thyroid cancer	2.25e-05	0.000991	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.25e-05	0.000988	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HPGD—thyroid cancer	2.2e-05	0.000967	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.12e-05	0.000933	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.02e-05	0.000888	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RXRA—thyroid cancer	2.01e-05	0.000886	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.96e-05	0.000862	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—thyroid cancer	1.96e-05	0.000861	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRG1—thyroid cancer	1.96e-05	0.000861	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.92e-05	0.000843	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.85e-05	0.000814	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.83e-05	0.000804	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—thyroid cancer	1.76e-05	0.000773	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.75e-05	0.000769	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.7e-05	0.000746	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—thyroid cancer	1.68e-05	0.000741	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—thyroid cancer	1.68e-05	0.000739	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—thyroid cancer	1.49e-05	0.000656	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—thyroid cancer	1.48e-05	0.000651	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RXRA—thyroid cancer	1.47e-05	0.000646	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—thyroid cancer	1.43e-05	0.00063	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.42e-05	0.000625	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—thyroid cancer	1.39e-05	0.000612	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TPR—thyroid cancer	1.29e-05	0.000569	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—thyroid cancer	1.27e-05	0.00056	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.27e-05	0.00056	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—thyroid cancer	1.26e-05	0.000556	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TPR—thyroid cancer	1.26e-05	0.000555	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.26e-05	0.000555	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.000546	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—thyroid cancer	1.17e-05	0.000516	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.15e-05	0.000507	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—thyroid cancer	1.08e-05	0.000476	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.07e-05	0.000469	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—thyroid cancer	1.05e-05	0.000463	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.02e-05	0.00045	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—thyroid cancer	1.02e-05	0.000447	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—thyroid cancer	1e-05	0.00044	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—thyroid cancer	9.8e-06	0.000431	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—thyroid cancer	9.68e-06	0.000426	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—thyroid cancer	9.56e-06	0.000421	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—thyroid cancer	9.45e-06	0.000416	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—thyroid cancer	9.27e-06	0.000408	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.07e-06	0.000399	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—thyroid cancer	8.74e-06	0.000385	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—thyroid cancer	8.72e-06	0.000384	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RXRA—thyroid cancer	8.13e-06	0.000358	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RXRA—thyroid cancer	7.94e-06	0.000349	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.91e-06	0.000348	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—thyroid cancer	7.52e-06	0.000331	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—thyroid cancer	7.29e-06	0.000321	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—thyroid cancer	6.69e-06	0.000294	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—thyroid cancer	6.47e-06	0.000285	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—thyroid cancer	6.4e-06	0.000281	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—thyroid cancer	6.36e-06	0.00028	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—thyroid cancer	5.89e-06	0.000259	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—thyroid cancer	5.65e-06	0.000248	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—thyroid cancer	5.14e-06	0.000226	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—thyroid cancer	5.03e-06	0.000221	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—thyroid cancer	5.01e-06	0.000221	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.04e-06	0.000178	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—thyroid cancer	3.94e-06	0.000174	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—thyroid cancer	3.67e-06	0.000161	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—thyroid cancer	3.52e-06	0.000155	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—thyroid cancer	3.44e-06	0.000151	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—thyroid cancer	2.03e-06	8.93e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—thyroid cancer	1.98e-06	8.72e-05	CbGpPWpGaD
